Sunrest Lifescience Ratios

Sunrest Lifescience Ltd Ratios

The Sunrest Lifescience Ltd Ratios page provides a complete fundamental analysis of Sunrest Lifescience Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Sunrest Lifescience Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Sunrest Lifescience Ltd (NSE: SUNREST, BSE: 91669) is currently trading at ₹35, with a market capitalization of ₹15.02Cr. As a major player in the Health technology sector and Pharmaceuticals: major industry, Sunrest Lifescience Ltd remains a key stock for fundamental analysis using Sunrest Lifescience Ltd Ratios.

Sunrest Lifescience Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Sunrest Lifescience Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Sunrest Lifescience Ltd Ratios.

Historically, the Sunrest Lifescience Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0

The decline in Sunrest Lifescience Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Sunrest Lifescience Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

• 2024: 0
• 2023: 0
• 2022: 0

Sunrest Lifescience Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Sunrest Lifescience Ltd P/S ratio currently stands at 0, an important part of Sunrest Lifescience Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0
• 2023: 0
• 2022: 0

A stable or declining Sunrest Lifescience Ltd P/S ratio indicates cautious market sentiment.

Sunrest Lifescience Ltd Price to Cash Flow Ratio (P/CF)

The Sunrest Lifescience Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Sunrest Lifescience Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 0

The declining Sunrest Lifescience Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Sunrest Lifescience Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Sunrest Lifescience Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

• 2024: 0
• 2023: 0
• 2022: 0

Sunrest Lifescience Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Sunrest Lifescience Ltd EV/EBITDA ratio is currently 0, a key metric in Sunrest Lifescience Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0

Stable Sunrest Lifescience Ltd EV/EBITDA indicates balanced valuation.

Sunrest Lifescience Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Sunrest Lifescience Ltd D/E ratio is currently 0.74, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.74
• 2023: 0.43
• 2022: 0.69

Sunrest Lifescience Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Sunrest Lifescience Ltd ROE currently stands at 13.15%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 13.15
• 2023: 2.61
• 2022: 0

Sunrest Lifescience Ltd maintains stable profitability levels.

Sunrest Lifescience Ltd Ratios Analysis Summary

The Sunrest Lifescience Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Sunrest Lifescience Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Sunrest Lifescience Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.